121 related articles for article (PubMed ID: 20191281)
1. Selected demographic characteristics of Israeli Jewish women with high-grade cervical intraepithelial neoplasia (CIN3): a population-based study.
Kogan L; Menczer J; Shejter E; Liphshitz I; Barchana M
Arch Gynecol Obstet; 2011 Feb; 283(2):329-33. PubMed ID: 20191281
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Cervical Cancer and CIN3 in Jewish Women in Israel - Two Case Control Studies.
Bassal R; Schejter E; Bachar R; Perri T; Korach J; Jakobson-Setton A; Ben-David LH; Cohen D; Keinan-Boker L
Asian Pac J Cancer Prev; 2016; 17(4):2067-73. PubMed ID: 27221897
[TBL] [Abstract][Full Text] [Related]
3. Recent trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel.
Bassal R; Schejter E; Bachar R; Shapira H; Kaufman Z; Cohen D; Keinan-Boker L
Arch Gynecol Obstet; 2015 Aug; 292(2):405-13. PubMed ID: 25690481
[TBL] [Abstract][Full Text] [Related]
4. A population-based study of selected demographic characteristics of Israeli-Jewish women with cervical squamous cell carcinoma.
Menczer J; Kogan L; Schejter E; Liphshiz I; Barchana M
Arch Gynecol Obstet; 2011 Mar; 283(3):629-33. PubMed ID: 20623130
[TBL] [Abstract][Full Text] [Related]
5. Ethnic Disparities for Gynecologic Cancers in Israel.
Kadan Y; Fishman A; Helpman L
J Racial Ethn Health Disparities; 2020 Jun; 7(3):421-427. PubMed ID: 31768965
[TBL] [Abstract][Full Text] [Related]
6. The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women.
Loopik DL; IntHout J; Ebisch RMF; Melchers WJG; Massuger LFAG; Siebers AG; Bekkers RLM
Gynecol Oncol; 2020 Apr; 157(1):195-201. PubMed ID: 31973912
[TBL] [Abstract][Full Text] [Related]
7. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.
Strander B; Hällgren J; Sparén P
BMJ; 2014 Jan; 348():f7361. PubMed ID: 24423603
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study.
Loopik DL; IntHout J; Melchers WJG; Massuger LFAG; Bekkers RLM; Siebers AG
Eur J Cancer; 2020 Jan; 124():102-109. PubMed ID: 31760309
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
10. Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study.
Sand FL; Frederiksen K; Munk C; Jensen SM; Kjaer SK
Int J Cancer; 2018 May; 142(9):1759-1766. PubMed ID: 29218720
[TBL] [Abstract][Full Text] [Related]
11. Burden of human papillomavirus infection and related diseases in Israel.
Shavit O; Roura E; Barchana M; Diaz M; Bornstein J
Vaccine; 2013 Nov; 31 Suppl 8():I32-41. PubMed ID: 24229717
[TBL] [Abstract][Full Text] [Related]
12. The relative risk of noncervical high-risk human papillomavirus-related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population-based study.
Loopik DL; Ebisch RM; IntHout J; Melchers WJ; Massuger LF; Bekkers RL; Siebers AG
Int J Cancer; 2020 Aug; 147(3):897-900. PubMed ID: 31846057
[TBL] [Abstract][Full Text] [Related]
13. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
14. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and correlates of human papillomavirus genotypes among patients with cervical cancer and cervical intraepithelial neoplasia 3 in Israel.
Bassal R; Rosin LS; Schvimer M; Schejter E; Ozeryansky B; Kulik S; Bachar R; Shapira H; Sandbank J; Cohen D; Keinan-Boker L
J Low Genit Tract Dis; 2015 Apr; 19(2):161-4. PubMed ID: 25105719
[TBL] [Abstract][Full Text] [Related]
16. Risk of head-and-neck cancer following a diagnosis of severe cervical intraepithelial neoplasia: a nationwide population-based cohort study in Denmark.
Svahn MF; Munk C; Jensen SM; von Buchwald C; Frederiksen K; Kjaer SK
Gynecol Oncol; 2016 Jul; 142(1):128-132. PubMed ID: 27106016
[TBL] [Abstract][Full Text] [Related]
17. The effect of age at immigration on cervical cancer incidence: a population-based cohort study of 1 486 438 Israeli women.
Raz Y; Keinan-Boker L; Goren S; Soen-Grisaru G; Cohen D; Grisaru D
Int J Gynecol Cancer; 2019 Mar; 29(3):492-496. PubMed ID: 30833437
[TBL] [Abstract][Full Text] [Related]
18. See-and-Treat for High-Grade Cytology: Do Young Women Have Different Rates of High-Grade Histology?
Smith HJ; Leath CA; Huh WK; Erickson BK
J Low Genit Tract Dis; 2016 Jul; 20(3):243-6. PubMed ID: 27243140
[TBL] [Abstract][Full Text] [Related]
19. Incidence and costs of cervical intraepithelial neoplasia in the Korean population.
Chang HK; Seo SS; Myong JP; Yu YL; Byun SW
J Gynecol Oncol; 2019 May; 30(3):e37. PubMed ID: 30887758
[TBL] [Abstract][Full Text] [Related]
20. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lehtinen M; Paavonen J; Wheeler CM; Jaisamrarn U; Garland SM; Castellsagué X; Skinner SR; Apter D; Naud P; Salmerón J; Chow SN; Kitchener H; Teixeira JC; Hedrick J; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; De Carvalho NS; Germar MJ; Peters K; Mindel A; De Sutter P; Bosch FX; David MP; Descamps D; Struyf F; Dubin G;
Lancet Oncol; 2012 Jan; 13(1):89-99. PubMed ID: 22075171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
